Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration

Nephron

Volumn 76, Issue 3, 1997, Pages 345-350

  Montilla, P ^a   Tunez I ^a   Muñoz, Chikahide ^a   Lopez A ^a   Soria, J V ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Adriamycin; Antioxidants; Free radicals; Hyperlipidemia; Nephropathy

Indexed keywords

CATALASE; CHOLESTEROL; CREATININE; DOXORUBICIN; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; MELATONIN; PHOSPHOLIPID; PROTEIN; TRIACYLGLYCEROL; UREA;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG INDUCED DISEASE; HYPERLIPIDEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0030852011     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190202     Document Type: Article

References (28)

1. Beretazolli C, Chicli T, Ricevuti G, Solida E: Chronic toxicity of Adriamycin: A new anli-ncoplastic antibiotic, Toxicol Appi Pharmacol 1972:21:287-301.
2. Suzuki Y, Ohnuma T, Goldsmith MA: Nephrotoxic effects of Adriamycin in rabbits, Fed Proc 1978:37:320.
3. Fajardo LF, Eltthringham J, Stewart J, Kaluber M: Adriamycin nephrotoxicity, Lab Invest 1980:43:242-253.
4. Bcrtani T, Poggi A, Pozzoni R, Delaini F, Sacelli G, Thoua Y, Mecca G, Rcmuzzi G, Donatti MB: Adriamycin induced nephrotic syndrome in rats: Sequence pathologic events, Lab Invest 1982:46:16-23.
5. Okuda S, Oh Y, Tsuruda H, Onovuma K, Fujimi S, Fujishima M: Adriamycin induced nephropathy as a model of chronic progressive glomerular disease, Kidney Int 1986:29:502-510.
6. Canepa A, Ghiggeri GM, Ginevri F, Trivelli A, Perfumo F, Gusmano R: Modulation of proteinuria and renal xanthine oxidase activity by dietary- proteins in acute Adriamycin nephrosis in rats: Lack of correlation with intra- and extracellular antino acids, Nephron 1992:60: 342-348.
7. Weening J, Rennke H: Glomerular permeability and polyanion Adriamycin nephrosis in the rat, Kidney Int 1983:24:152-159.
8. Bertani T, Cutillo F, Zoja C, Broggini M, Rcmuzzi G: Tubulo-interstitial lesions mediate renal damage in Adriamycin glomerulopathy, Kidney Int 1986;30:488-496.
9. Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T: Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis, J Clin Invest 1985:75:94-101.
10. Bristow M, Minobe W, Biliingham M, Marmor J, Johnson G, Ishimoto B, Shagcman W, Daniels J: Anthracvcline-associatcd cardiac and renal damage in rabbits: Evidence for mediation by vasoactive substances, Lab Clin Invest 1981:45:157-168.
11. Bakker W, Kalicharan D, Donga J, Hulstaert C, Hardonk M: Decreased ATPase activity in Adriamycin nephrosis is independent of proteinuria, Kidney Int 1987;31:704-709.
12. Ichikawa I, Kimaya S, Yoshioka T: Renal antioxidant enzymes: Their regulation and function, Kidney Int 1994;45:1-9.
13. Tan D, Chen LD, Poeggclcr B, Manchester LD, Reiter JR: Melatonin: A potent, endogenous hydroxyl radical scavenger, Etidocr J 1993:1: 57-60.
14. Reiter JR, Pocggcler B, Tan D, Chen L, Manchester LC, Guerrero JM: Antioxidant capacity of melatonin: Novel action not requiring receptor, Neuroendocrinol Lett 1993;15:103-116.
15. Pocggcler B, Saarela S, Reiter J R, Tan D, Chen LK, Manchester LC, Barlow-Warren LR: Melatonin: A highly potent endogenous radical scavenger and electron donor, New aspects of the oxidation chemistry of this indole assessed in vivo, Ann NY Acad Sci 1994;738:419-420.
16. Reiter JR: Functional plciotropy of the neuro-hormone melatonin: Antioxidant protection and neuroendocrine regulation, Front Neuro endocrinol 1995:16:383-415.
17. C'iaccio M, Valenza M, Tesoriere L, Bongiorno B, Albiero R, Livrea MA: Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo, Arch Biochem Bio-phys 1993;302:105-108.
18. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxidation in animal tissue thiobarbituric acid reaction, Anal Biochem 1979:95:531-538.
19. Thomas G, Skrinska V: Determination of glutathione in human platelets, Clin Chem 1985: 31:350-351.
20. Acbi H: Catalase; in Bergmeyer HU (ed): Methods in Enzymatic Analysis, Wcinhcim, Verlag Chemie, 1982. vol 3. pp 273-282.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent, J Biol Chem 1951:193:265-275.
22. Okasora T, Takikawa T, Utsunomiya Y: Suppressive elicct of Superoxide dismutase on Adriamycin nephropathy, Nephron 1992:60: 199-203.
23. Washio M, Nanishi F, Onoyama K, Fujishima M: Alpha tocopherol improves focal glomerulosclerosis in rats with Adriamycin-induccd progressive renal failure, Nephron 1994:68: 347-352.
24. Kuo CH, Hook JB: Depletion of renal glutathione and nephrotoxicity by ccphaloridine, ce-phalothin and gentamycin in male Sprague-Dawlev rats, LifeSci 1982.31:225-260.
25. McMurtry RJ, Snodgrass WR, Mitchell JR: Renal necrosis, glutathione depletion, and covalent binding acetaminophen, Toxicol Appl Pharmacol 1978;46:87-100.
26. Tan DX, Reiter RJ, Chen LD, Poeggelcr B, Manchester LD, Barlow-Waldcn LR: Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole in vivo, Carcinogenesis 1994:15:215-218.
27. Vijayalaxmi V, Reiter RJ, Meltz ML: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage, Mutat Res 1995:346:23-31.
28. Vijayalaxmi V, Reiter RJ, Sewerynck E, Peoggel-er B, Leal BZ, Meltz ML: Marked reduction of radiation-induced micronuclei in human blood lymphocytes prctreated with melatonin, Rad Res 1995:143:102-106.